Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.81 USD
Change Today -0.43 / -5.22%
Volume 270.0K
MDGN On Other Exchanges
As of 8:04 PM 07/29/15 All times are local (Market data is delayed by at least 15 minutes).

medgenics inc (MDGN) Key Developments

Medgenics, Inc.(AMEX:MDGN) added to Russell 2000 Index

Medgenics, Inc. will be added to Russell 2000 Index

Medgenics, Inc.(AMEX:MDGN) added to Russell 3000 Index

Medgenics, Inc. will be added to the Russell 3000 Index.

Medgenics, Inc. Announces Board Appointments

On June 9, 2015, the Board of Directors of Medgenics, Inc., elected Barbara G. Duncan to fill one of its vacant directorships, effective July 22, 2015. In connection with Ms. Duncan's election as a Director, the Compensation Committee of the Company's Board of Directors recommended. In addition, as of June 9, 2015, the Company and Ms. Duncan entered into a non-executive director appointment letter agreement setting forth, among other things, Ms. Duncan's duties as a director. Pursuant to the agreement, Ms. Duncan will be entitled to the same cash fees for her services as a director as the other non-executive directors of the Company. Ms. Duncan also agreed to maintain the confidentiality of all confidential business information, to disclose conflicts of interest to the Company and not to compete or solicit certain employees or other parties with which the Company does business for a period ending twelve months following the termination of her directorship.

Medgenics, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2015

Medgenics, Inc. announced unaudited earnings results for the first quarter ended March 31, 2015. For the quarter, operating loss was USD 7,888,000 against USD 5,235,000 a year ago. Loss before taxes on income was USD 8,921,000 against USD 5,352,000 a year ago. Loss was USD 8,922,000 against USD 5,357,000 a year ago. Basic and diluted loss per share was USD 0.36 against USD 0.28 a year ago.

Medgenics, Inc., Q1 2015 Earnings Call, Apr 17, 2015

Medgenics, Inc., Q1 2015 Earnings Call, Apr 17, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDGN:US $7.81 USD -0.43

MDGN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for MDGN.
View Industry Companies

Industry Analysis


Industry Average

Valuation MDGN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 8.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDGENICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at